Labcorp (LH) Tops Q3 EPS by 1c; Offers FY22 EPS Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/4/2026
- Wall Street ends higher after Democrats win Congress; data center stocks tumble
- What the Democratic sweep in the midterms means for markets
- SpaceX, Tesla slide as election risks mount, Morgan Stanley turns bullish
- CVS Health plans to split into two public companies by 2028
- AI sector outlook darkens as Democrat wins threaten $900B capex cycle
Tweet
Share
E-mail
Get Alerts LH Hot Sheet
Price: $367.79 +3.92%
Financial Fact:
Restructuring and other special charges: 22.8M
Today's EPS Names:
COHR, ATS, SICP, More
Financial Fact:
Restructuring and other special charges: 22.8M
Today's EPS Names:
COHR, ATS, SICP, More
Join SI Premium – FREE
Labcorp (NYSE: LH) reported Q3 EPS of $4.68, $0.01 better than the analyst estimate of $4.67. Revenue for the quarter came in at $3.6 billion versus the consensus estimate of $3.8 billion.
GUIDANCE:
Labcorp sees FY2022 EPS of $19.25-$20.25, versus the consensus of $20.19.
For earnings history and earnings-related data on Labcorp (LH) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Deluxe Corp. (DLX) Tops Q3 EPS by 11c; offers guidance
- Dave Inc. (DAVE) Tops Q3 EPS by 31c; offers guidance
- Inter Parfums (IPAR) Tops Q3 EPS by 33c ; Offers Guidance
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
